BioLargo shareholders approve reverse split authorization; board has no immediate plans

BIOLARGO, INC.

All seven director nominees elected, including Dennis Calvert, Kenneth Code, Linda Park.
Advisory say-on-pay passed with 54.7% of votes present (103.9M for, 7.9M against).
Ratification of Hacker Johnson & Smith as auditor approved with 99.3% for.
Reverse stock split authorized (51.8% of outstanding shares) but board has no immediate plans to implement.
CEO states reverse split would only be used if needed to meet minimum price for Nasdaq/NYSE uplisting.

item 5.07item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.